Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1831 AL 1845

[Update on diagnostics and therapy of idiopathic Parkinson's disease]

Waldthaler J, Timmermann L.

Fortschr Neurol Psychiatr. 2019 Aug;87(8):445-461. doi: 10.1055/a-0952-8075. Epub 2019 Aug 20.

Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests

Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier JM, Fajloun Z.

Molecules. 2019 Aug 19;24(16):2997. doi: 10.3390/molecules24162997.

Eye-of-the-tiger Sign in Neurodegeneration with Brain Iron Accumulation

Goldberg M, Malik K, Jiswant R, Khaku AS.

Cureus. 2019 Jun 18;11(6):e4936. doi: 10.7759/cureus.4936.

Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease

Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.

J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. doi: 10.1007/s00702-019-02065-1. Epub 2019 Aug 20.

Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease

Trist BG, Hare DJ, Double KL.

Aging Cell. 2019 Dec;18(6):e13031. doi: 10.1111/acel.13031. Epub 2019 Aug 20.

Effects of treadmill training on the balance, functional capacity and quality of life in Parkinson's disease: A randomized clinical trial

Arfa-Fatollahkhani P, Safar Cherati A, Habibi SAH, Shahidi GA, Sohrabi A, Zamani B.

J Complement Integr Med. 2019 Aug 21;17(1):/j/jcim.2019.17.issue-1/jcim-2018-0245/jcim-2018-0245.xml. doi: 10.1515/jcim-2018-0245.

Subjective cognitive complaints in patients with Parkinson's disease

Kjeldsen PL, Damholdt MF.

Acta Neurol Scand. 2019 Dec;140(6):375-389. doi: 10.1111/ane.13158. Epub 2019 Oct 9.

Tremor habituation to deep brain stimulation: Underlying mechanisms and solutions

Fasano A, Helmich RC.

Mov Disord. 2019 Dec;34(12):1761-1773. doi: 10.1002/mds.27821. Epub 2019 Aug 21.

A Stage-Based Approach to Therapy in Parkinson's Disease

Carrarini C, Russo M, Dono F, Di Pietro M, Rispoli MG, Di Stefano V, Ferri L, Barbone F, Vitale M, Thomas A, Sensi SL, Onofrj M, Bonanni L.

Biomolecules. 2019 Aug 20;9(8):388. doi: 10.3390/biom9080388.

Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study

Khlebtovsky A, Steiner I, Treves T, Djaldetti R.

Clin Transl Sci. 2019 Nov;12(6):586-590. doi: 10.1111/cts.12684. Epub 2019 Sep 24.

Early mechanisms of amyloid fibril nucleation in model and disease-related proteins

Morel B, Conejero-Lara F.

Biochim Biophys Acta Proteins Proteom. 2019 Nov;1867(11):140264. doi: 10.1016/j.bbapap.2019.140264. Epub 2019 Aug 19.

An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

Prasuhn J, Brüggemann N, Hessler N, Berg D, Gasser T, Brockmann K, Olbrich D, Ziegler A, König IR, Klein C, Kasten M.

Neurol Res Pract. 2019 Aug 23;1:31. doi: 10.1186/s42466-019-0033-1. eCollection 2019.

Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders

Li Y, Xie L, Huang T, Zhang Y, Zhou J, Qi B, Wang X, Chen Z, Li P.

Front Neurosci. 2019 Aug 8;13:778. doi: 10.3389/fnins.2019.00778. eCollection 2019.

Direct Electrical Stimulation in Electrocorticographic Brain-Computer Interfaces: Enabling Technologies for Input to Cortex

Caldwell DJ, Ojemann JG, Rao RPN.

Front Neurosci. 2019 Aug 7;13:804. doi: 10.3389/fnins.2019.00804. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias